Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders

Behavioural Pharmacology

Volumn 11, Issue 3-4, 2000, Pages 235-242

  Aloe, L ^a   Iannitelli, A ^b   Angelucci, F ^a   Bersani, G ^b   Fiore, M ^a  

^a CNR   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Animal models; Behavior; Brain derived neurotrophic factor (BDNF); Maldevelopment; Nerve growth factor; Neurotrophins; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN;

ADULTHOOD; AGGRESSIVENESS; ANIMAL MODEL; ANXIETY; BRAIN DEVELOPMENT; BRAIN LEVEL; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; ENVIRONMENTAL FACTOR; EXPERIMENTAL ANIMAL; HUMAN; NERVE CELL; NONHUMAN; REVIEW; SCHIZOPHRENIA;

EID: 0033936808     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200006000-00007     Document Type: Review

References (106)

1. Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE, Jones EG (1996). Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 53:425-436.
2. Alleva E, Aloe L (1989). Physiological roles of nerve growth factor in adult rodents: a biobehavioral perspective. Int J Comp Psychol 2:147-163.
3. Aloe L, Tirassa P (1992). The effect of long-term alcohol intake on brain NGF-target cells of aged rats. Alcohol 9:299-304.
4. Aloe L, Alleva E, Bôhm A, Levi-Montalcini R (1986). Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream. Neurobiology 83: 6184-6187.
5. Aloe L, Bracci-Laudiero L, Alleva E, Lambiase A, Micera A, Tirassa P (1994). Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes. Proc Natl Acad Sci USA 91:10440-10444.
6. Aloe L, Tuveri MA, Guerra G, Pinna L, Tirassa P, Micera A, Alleva E (1996). Changes in human plasma nerve growth factor level after chronic alcohol consumption and withdrawal. Alcohol Clin Exp Res 20:462-465.
7. Aloe L, Iannitelli A, Bersani G, Alleva E, Angelucci F, Maselli P, Manni L (1997). Haloperidol administration in humans lowers plasma nerve growth factor level: evidence that sedation induces opposed effect of arousal. Neuropsychobiology 36:65-68.
8. Altar CA (1999). Neurotrophins and depression. Trends Pharmacol Sci 20:59-61.
9. Angelucci F, Cimino M, Balduini W, Pistillo L, Aloe L (1997). Prenatal ethanol exposure causes differential effects in the nerve growth factor and its receptors in basal forebrain of preweaning and adult rats. J Neural Transpl Plasticity 6:63-71.
10. Angelucci F, Fiore M, Cozzari C, Aloe L (1999). Prenatal ethanol effect on NGF level, NPY and ChAT immunoreactivity in mouse entorhinal cortex: a preliminary study. Neurotoxicol Teratol 21:415-425.
11. Barde YA (1989). Trophic factors and neuronal survival. Neuron 2:1525-1534.
12. Barde YA (1990). The nerve growth factor family. Prog Growth Factor Res 2:237-248.
13. Barnes DE, Walker DW (1981). Prenatal ethanol exposure permanently reduces the number of pyramidal neurons in rat hippocampus. Dev Brain Res 1:333-340.
14. Bayer SA, Altman J (1987). Directions in neurogenetic gradients and patterns of anatomical connections in the telencephalon. Progr Neurobiol 29:57-106.
15. Bengzon J, Kokaia Z, Kokaia M, Leanza G, Nilsson OG, Persson H, Lindvall O (1993). Regulation of neurotrophin and trkA, trkB and trkC tyrosine kinase receptor messenger RNA expression in kindling. Neuroscience 53:433-446.
16. Bersani G, Aloe L, Iannitelli A, Maselli P, Alleva E, Angelucci F et al. (1996). Electroconvulsive therapy (ECT) as stress, increases nerve growth factor (NGF) plasma levels in psychiatric patients. Eur Psych 11 (suppl 4):334.
17. Bersani G, Aloe L, Iannitelli A, Maselli P, Alleva E, Angelucci F, Pancheri P (1999). Nerve Growth Factor plasma levels in schizophrenic patients: a pilot study. Schizophr Res 37:197-203.
18. Bersani G, Iannitelli A, Fiore M, Angelucci F, Aloe L (2000). Data and hypotheses on the role of nerve growth factor and other neurotrophins in psychiatric disorders. Med Hypoth, in press.
19. Bogerts B, Falkai P, Haupts M, Greve B, Ernst S, Tapernon-Franz U (1990). Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection. Schizophr Res 3:295-301.
20. Bonthius DJ, West JR (1990). Alcohol-induced neuronal loss in developing rats: increased brain damage with binge exposure. Alcohol Clin Exp Res 14:107-118.
21. Breier A, Schreiber JL, Dyer J, Pickar D (1991). National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiat 48:239-242.
22. Cattabeni F, Di Luca M (1997). Developmental models of brain dysfunction induced by targeted cellular ablations with methylazoxymethanol. Physiol Rev 77:199-215.
23. Chao MV, Hempstead BL (1995). p75 and Trk: a two-receptor system. Trends Neurosci 18:321-326.
24. Cimino M, Cattabeni F, Di Luca M, Peruzzi G, Andena M, Tirassa P et al. (1996). Levels of NGF, p75NGFR and ChAT immunoreactivity in brain of adult and aged microencephalic rats. Neurobiol Aging 17:137-142.
25. Cipriano P, Silvestrini C, Iannitelli A, Bersani G (1999). Dati attuali sulla neuropatologia della schizofrenia. Minerva Psichiatrica 40:81-107.
26. Connor B, Dragunow M (1998). The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Rev 27:1-39.
27. Connor J, Fass-Holmes B, Varon S (1994). Changes in nerve growth factor immunoreactivity following entorhinal cortex lesion: possible molecular mechanism regulating cholinergic sprouting. J Comp Neural 345:409-418.
28. Davis JO, Phelps JA, Bracha HS (1995). Prenatal development of monozygotic twins and concordance for schizophrenia. Schizophrenia Bull 21:357-366.
29. De Lisi E (1997). Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? Schizophr Res 23:119-129.
30. Eaton WW, Tien AY, Poeschla BD (1995). Epidemiology of schizophrenia. In: Advances in the Neurobiology of Schizophrenia. Den Boer JA, Westenberg HGM, van Praag HM (editors). Chichester: John Wiley and Sons, pp. 27-57.
31. Ebendal T (1989). NGF in CNS: experimental data and clinical implications. Prog Growth Factor Res 1:143-159.
32. Ernfors P, Bengzon J, Kokaia Z, Persson H, Lindvall O (1991). Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron 7:165-176.
33. Fiore M, Talamini L, Angelucci F, Koch T, Aloe L, Korf J (1999). Prenatal methylazoxymethanol acetate alters behavior and brain NGF levels in young rats: a possible correlation with the development of schizophrenia-like deficits. Neuropharmacology 38:857-869.
34. Fish B (1977). Neurobiologic antecedents of schizophrenia in children: evidence for an inherited, congenital neurointegrative defect. Arch Gen Psychiat 34:1297-1313.
35. Follesa P, Gale K, Mocchetti I (1994). Regional and temporal pattern of expression of nerve growth factor and basic fibroblast growth factor mRNA in rat brain following electroconvulsive shock. Exp Neurol 127:37-44.
36. Freedman R, Stromberg I, Seiger A, Olson L, Nordstrom AL, Wiesel FA et al. (1992). Initial studies of embryonic transplants of human hippocampus and cerebral cortex derived from schizophrenic women. Biol Psychiat 32:1148-1163.
37. Freedman R, Stromberg I, Nordstrom AL, Seiger A, Olson L, Bygdeman M et al. (1994). Neuronal development in embryonic brain tissue derived from schizophrenic women and grafted to animal hosts. Schizophr Res 13:259-270.
38. Galderisi S, Mucci A, Maj M (1997). Neuropsicologia delle sindromi shizofreniche. Giorn Ital Psicopat 3:241-260.
39. Gall CM, Isackson PJ (1989). Limbic seizures increase neuronal production of messenger RNA for nerve growth factor. Science 245:758-761.
40. Gall C, Murray K, Isackson PJ (1991). Kainic acid-induced seizures stimulate increased expression of nerve growth factor mRNA in rat hippocampus. Mol Brain Res 9:113-123.
41. Garofalo L, Ribeiro-da-Silva A, Cuello AC (1992). Nerve growth factor-induced synaptogenesis and hypertrophy of cortical cholinergic terminals. Proc Nat Acad Sci USA 89:2639-2643.
42. Gibbs RB (1994). Estrogen and nerve growth factor-related system in brain. Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging. Ann NY Acad Sci 743:165-199.
43. Gold JM, Weinberger DR (1995). Cognitive deficits and the neurobiology of schizophrenia. Curr Opinion Neurobiol 5:225-230.
44. Gwag BJ, Sessler FM, Waterhouse BD, Springer JE (1993). Regulation of nerve growth factor mRNA in the hippocampal formation: effects of N-methyl-D-aspartate receptor activation. Exp Neurol 121:160-171.
45. Hardman R, Evans D, Fellows L, Hayes B, Rupniak J, Barnes J, Higging G (1997). Evidence for recovery of spatial learning following entorhinal cortex lesions in mice. Brain Res 758:187-200.
46. Hattori M, Nanko S (1995). Association of neurotrophin-3 gene variant with severe forms of schizophrenia. Biochem Biophys Res Com 209:513-518.
47. Iannitelli A, Aloe L, Bersani G, Maselli P, Angelucci F, Bracci-Laudiero L et al. (1995). Seizure-induced serum NGF levels increase after ECT in psychiatric patients: a first pilot study in man. Behav Pharmacol 6 (suppl 1): 93-94.
48. Iannitelli A, Bersani G, Aloe L (1998). Dati acquisiti ed ipotesi emergenti sul ruolo delle neurotrofine, in particolare dell'NGF, in patologie di natura psichiatrica. Giorn Ital Psicopat 4:383-392.
49. Ibanez J, Herrero MT, Insausti R, Belzunengui T, Gonzalo LM (1992). Short-term ethanol intoxication in rat. Effect on the entorhinal cortex. Neurosci Lett 138:199-201.
50. Ibanez J, Herrero M, Insausti R, Belzunegui T, Tunún T, Garcïa-Bragado F, Gonzalo L (1995). Chronic alcoholism decreases neuronal nuclear size in the human entorhinal cortex. Neurosci Lett 183:71-74.
51. Isackson PJ, Huntsman MM, Murray KD, Gall CM (1991). BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF. Neuron 6:937-948.
52. Jackob H, Beckman H (1986). Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65:303-326.
53. Jones KL, Smith DW (1973). Recognition of the fetal alcohol syndrome in early infancy. Lancet 2:999-1001.
54. Jones P, Murray RM (1991). The genetics of schizophrenia is the genetics of neurodevelopment. Br J Psychiat 158:615-623.
55. Kang H, Schumann EM (1996). A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity. Science 273:1402-1406.
56. Karson CN, Mrak RE, Husain MM, Griffin WS (1996). Decreased mesopontine choline acetyltransferase levels in schizophrenia. Correlations with cognitive functions. Mol Chem Neuropathol 29:181-191.
57. Keck PE Jr, Strakowski SM, McElroy SL (2000). The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia. J Clin Psychiatry 61:4-9.
58. Kendler KS, Diehl SR (1993). The genetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophr Bull 19:261.
59. Kendler KS, Tsuang MT (1988). Outcome and familial psychopathology in schizophrenia. Arch Gen Psychiatry 45:338-346.
60. Kety SS (1975). Letter: accuracy of diagnosis and genetics factors in schizophrenia. Am J Psychiat 132:458-459.
61. Larsson PT, Olsson G, Hjemdahl P, Nilsson J (1989). Mental stress and adrenaline increase plasma growth factor activity in humans. Acta Physiol Scand 137:565-566.
62. Lauterborn JC, Isackson PJ, Gall CM (1994). Seizure-induced increases in NGF mRNA exhibit different time courses across forebrain regions and are biphasic in hippocampus. Exp Neurol 125:22-40.
63. Levi-Montalcini R (1987). The nerve growth factor 35 years later. Science 237:1154-1162.
64. Levi-Montalcini R, Aloe L, Alleva E (1990). A role of nerve growth factor in nervous, endocrine and immune systems. Prog NeuroEndocrinImmunol 3:1-10.
65. Luppi P, Levi-Montalcini R, Bracci-Laudiero L, Bertolini A, Arletti R, Tavernari D et al. (1993). NGF is released into plasma during human pregnancy: an oxytocin-mediated response? NeuroReport 4:1063-1065.
66. Mack KJ, Yi S, Chang S, Millan N, Mack P (1995). NGFI-C expression is affected by physiological stimulation and seizures in the somatosensory cortex. Mol Brain Res 29:140-146.
67. Maestripieri D, De Simone R, Aloe L, Alleva E (1990). Social status and nerve growth factor serum levels after agonistic encounters in mice. Phys Behav 47:161-164.
68. Matsuda H, Koyama H, Oikawa M, Yoshihara T, Keneko M (1991). Nerve growth factor-like activity detected in equine peripheral blood after running exercise. J Vet Med A 38:557-559.
69. Matsumoto H, Spatz M, Laquer GL (1972). Quantitative changes with age in the DNA content of methylazoxymethanol-induced microencephalic rat brain. J Neurochem 19:297-306.
70. Mednick SA, Machon RA (1988). Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 45:189-192.
71. Mobley WC, Rutkowsky JL, Tennekoon GI, Gemsky J, Buchanan K, Johnston MV (1986). Nerve Growth Factor increases choline acetyltransferase activity in developing basal forebrain neurons. Mol Brain Res 1:53-62.
72. Mohammed A, Winbland B, Ebendal T, Larkfors L (1990). Environmental influence on behaviour and nerve growth factor in the brain. Brain Res 528:67-72.
73. Mohammed A, Henriksson BG, Soderstrom S, Ebendal T, Olsson T, Seckl JR (1993). Environmental influences on the central nervous system and their implications for the aging rat. Brain Res 57:183-191.
74. Murray RM, Jones P, O'Challaghan E, Takey N, Sham P (1992). Genes, viruses and neurodevelopmental schizophrenia. J Psychiatry Res 26:224-235.
75. Nanko S, Hattori M, Kuwata S, Sasaki T, Fukuda R, Dai XY, et al. (1994). Neurotrophin-3 gene polymorphism associated with schizophrenia. Acta Psychiat Scand 89:390-392.
76. Neeper SA, Gûmez-Pinilla F, Choi J, Cotman CW (1996). Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 726:49-56.
77. Oda Y. (1999) Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system. Pathol Int 49:921-937.
78. Raedler TJ, Knable MB, Weinberger DR (1998). Schizophrenia as a developmental disorder of the cerebral cortex. Curr Opin Neurobiol 8:157-161
79. Riva MA, Gale K, Mocchetti I (1992). Basic fibroblast growth factor mRNA increases in specific brain regions following convulsive seizures. Mol Brain Res 15:311-318.
80. Rocamora N, Palacios JM, Mengod G (1992). Limbic seizures induce a differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3, in the rat hippocampus. Mol Brain Res 13:27-33.
81. Rocamora N, Massieu L, Boddeke HWGM, Palacio JM, Mengod G (1994). Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 mRNAs in adult rat brain after intrahippocampal injection of quinolinic acid. Mol Brain Res 26:89-98.
82. Rutter M, Silberg J, O'Connor T, Simonoff E (1999). Genetics and child psychiatry: I Advances in quantitative and molecular genetics. J Child Psychol Psychiatry 40:3-18.
83. Rylett RJ, Williams LR (1994). Role of neurotrophins in cholinergic-neuron function in the adult and aged CNS. Trends Neurosci 17:486-490.
84. Sato K, Kashihara K, Morimoto K, Hayabara T (1996). Regional increases in brain-derived neurotrophic factor and nerve growth factor mRNAs during amygdaloid kindling, but not in acidic and basic fibroblast growth factor mRNAs. Epilepsia 37:6-14.
85. Selten JP, Vaan Dursen R, Van Der Graaf Y, Gispen-De Wied C, Kahn RS (1997). Second-trimester exposure to maternal stress is a possible risk factor for psychotic illness in the child. Schizophr Res 24:258.
86. Sham PC, O'Callaghan E, Takei N, Murray GK, Hare EH, Murray RM (1992). Schizophrenia following pre-natal exposure to influenza epidemics between 1939 and 1960. Br J Psychiatry 160:461-466.
87. Spillantini MG, Aloe L, Alleva E, De Simone R, Goedert M, Levi-Montalcini R (1989). Nerve growth factor mRNA and protein increase in hypothalamus in a mouse model of aggression. Proc Natl Acad Sci USA 86:8555-8559.
88. Spohr HL, Williams J, Steinhausen HC (1993). Prenatal alcohol exposure and long-term developmental consequences. Lancet 341:907-910.
89. Susser E, Neugebauer R, Hock HW, Brown AS, Lin S, Labovitz D, Gorman JM (1996). Schizophrenia after prenatal famine. Arch Gen Psychiatry 5:25-31.
90. Swerdlow NR, Braff DL, Geyer MA (1990). Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology 101:414-420.
91. Talamini LM, Koch T, Ter Horst GJ, Korf J (1998). Methylazoxymethanol acetate-induced abnormalities in the entorhinal cortex of the rat; parallels with morphological findings in schizophrenia. Brain Res 789:293-306.
92. Talamini LM, Koch T, Luiten PGM, Koolhaas JM, Korf J (1999). Interruption of early cortical development affect limbic association areas and social behaviour in rats; possible relevance for neurodevelopmental disorders. Brain Res 847:105-120.
93. Thoenen H, Bandtlow C, Heumann R (1987). The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rer Physiol Biochem Pharmacol 109:145-178.
94. Van Praag H, Alberch J, Perez-Navarro E, Wu H, Ou P, Black I, Dreyfus C (1996). Unilateral neonatal hippocampal lesions alter septal innervation and trophism in the entorhinal cortex. Exp Neurol 141:130-140.
95. Vorhees CV (1989). A fostering/crossfostering analysis of the effects of prenatal ethanol exposure in a liquid diet on offspring development and behavior in rats. Neurotoxicol Teratol 11:115-120.
96. Watson MA, Milbrandt J (1989). The NGF-B gene, a transcriptionally inducible member of the steroid receptor gene super-family: genomic structure and expression in rat brain after seizure induction. Mol Cell Biol 9:4213-4219.
97. Weinberger DR (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:666-669.
98. Weinberger DR (1995). Schizophrenia: from neuropathology to neurodevelopment. Lancet 346:552-557.
99. Weinberger DR, Lipska BK (1995). Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr Res 16:87-110.
100. West JR, Dewey SL, Cassell MD (1984). Prenatal ethanol exposure alters the post-lesion reorganization (sprouting) of acetyl-cholinesterase staining in the dentate gyrus of adult rats. Brain Res 314:83-95.
101. Whittemore SR, Seiger Å (1987). The expression, localization and functional significance of nerve growth factor in the central nervous system. Brain Res Rev 12:439-464.
102. Witter M, Groenewegen H, Lopez-da Silva F, Lohman A (1989). Functional organization of the extrinsc and intrinsic circuitry of the parahippocampal region. Prog Neurobiol 33:161-253.
103. Woods BT (1998). Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry 155:1661-1670.
104. Wright SA, Takei N, Rifkin L, Murray RM (1995). Maternal influenza, obstetric complication and schizophrenia. Am J Psychiatry 152:1714-1729.
105. Yuen EC, Mobley WC (1996). Therapeutic potential of neurotrophic factors for neurological disorders. Ann Neurol 40:346-354.
106. Zaidel DW, Esiri MM, Harrison PJ (1997). Size, shape and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia. Am J Psychiatry 154:812-818.